Mark E Cooper

Haematopoiesis and Leukocyte Biology, Baker Heart and Diabetes Institute, Melbourne, Australia (M.K.S.L., M.J.K., D.D., N.M.J.H., M.C.F., A.A.-S., C.B.-V., O.D.C., F.B., E.M., A.J.M.).

View Article and Find Full Text PDF

March 2021

Clinicopathologic features and prognostic factors in older patients with biopsy-proven diabetic nephropathy.

Authors:

Lijun Zhao Honghong Ren Rui Zhang Tingli Wang Yutong Zou Huan Xu Lin Li Mark E Cooper Fang Liu

Int Urol Nephrol 2021 Jan 3. Epub 2021 Jan 3.

Division of Nephrology, West China Hospital of Sichuan University, No. 37, Guoxue Alley, Chengdu, Sichuan, China.

View Article and Find Full Text PDF

January 2021

Targeted deletion of NADPH-Oxidase Nox4 from proximal tubules is dispensable for diabetic kidney disease development.

Authors:

Vicki Thallas-Bonke Sih Min Tan Runa S Lindblom Matthew Snelson Cesare Granata Jay Chandra Jha Karly C Sourris Adrienne Laskowski Anna Watson Michel Tauc Isabelle Rubera Guoping Zheng Ajay M Shah David C H Harris Mahmoud H Elbatreek Phillip Kantharidis Mark E Cooper Karin Jandeleit-Dahm Melinda T Coughlan

Nephrol Dial Transplant 2020 Dec 24. Epub 2020 Dec 24.

Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia.

View Article and Find Full Text PDF

December 2020

Combining glomerular basement membrane and tubular basement membrane assessment improves the prediction of diabetic end-stage renal disease.

Authors:

Lijun Zhao Junlin Zhang Song Lei Honghong Ren Yutong Zou Lin Bai Rui Zhang Huan Xu Lin Li Yuancheng Zhao Mark E Cooper Nanwei Tong Jie Zhang Fang Liu

J Diabetes 2020 Dec 22. Epub 2020 Dec 22.

Division of Nephrology, West China Hospital of Sichuan University, Chengdu, China.

View Article and Find Full Text PDF

December 2020

Contemporary Management of Heart Failure in Patients With Diabetes.

Authors:

James A Shaw Mark E Cooper

Diabetes Care 2020 Dec;43(12):2895-2903

Baker Heart and Diabetes Institute, Melbourne, Australia

View Article and Find Full Text PDF

December 2020

Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes.

Authors:

Thirunavukkarasu Sathish Robyn J Tapp Mark E Cooper Paul Zimmet

Diabetes Metab 2020 Oct 28:101204. Epub 2020 Oct 28.

Central Clinical School, Monash University, The Alfred Centre, 99 Commercial Road, Melbourne, VIC 3004, Australia. Electronic address:

View Article and Find Full Text PDF

October 2020

Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial.

Authors:

Hyunju Kim Dan Wang John Chalmers Min Jun Sophia Zoungas Michel Marre Pavel Hamet Stephen Harrap Giuseppe Mancia Neil R Poulter Mark E Cooper Mark Woodward Elizabeth Selvin Casey M Rebholz

J Diabetes 2020 Dec 27;12(12):929-941. Epub 2020 Jul 27.

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

View Article and Find Full Text PDF

December 2020

Disparate Effects of Diabetes and Hyperlipidemia on Experimental Kidney Disease.

Authors:

Anna M D Watson Eleanor A M Gould Sarah C Moody Priyadharshini Sivakumaran Karly C Sourris Bryna S M Chow Audrey Koïtka-Weber Terri J Allen Karin A M Jandeleit-Dahm Mark E Cooper Anna C Calkin

Front Physiol 2020 3;11:518. Epub 2020 Jun 3.

Central Clinical School, Monash University, Melbourne, VIC, Australia.

View Article and Find Full Text PDF

June 2020

Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis.

Circ Res 2020 Sep 22;127(7):877-892. Epub 2020 Jun 22.

Department of Physiology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia (A.J.M.).

View Article and Find Full Text PDF

September 2020

New-Onset Diabetes in Covid-19.

Authors:

Francesco Rubino Stephanie A Amiel Paul Zimmet George Alberti Stefan Bornstein Robert H Eckel Geltrude Mingrone Bernhard Boehm Mark E Cooper Zhonglin Chai Stefano Del Prato Linong Ji David Hopkins William H Herman Kamlesh Khunti Jean-Claude Mbanya Eric Renard

N Engl J Med 2020 08 12;383(8):789-790. Epub 2020 Jun 12.

University of Montpellier, Montpellier, France.

View Article and Find Full Text PDF

August 2020

Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial.

Authors:

Vlado Perkovic Robert Toto Mark E Cooper Johannes F E Mann Julio Rosenstock Darren K McGuire Steven E Kahn Nikolaus Marx John H Alexander Bernard Zinman Egon Pfarr Sven Schnaidt Thomas Meinicke Maximillian von Eynatten Jyothis T George Odd Erik Johansen Christoph Wanner

Diabetes Care 2020 08 22;43(8):1803-1812. Epub 2020 May 22.

Boehringer Ingelheim Norway KS, Asker, Norway.

View Article and Find Full Text PDF

August 2020

Empagliflozin modulates renal sympathetic and heart rate baroreflexes in a rabbit model of diabetes.

Authors:

Cindy Gueguen Sandra L Burke Benjamin Barzel Nina Eikelis Anna M D Watson Jay C Jha Kristy L Jackson Yusuke Sata Kyungjoon Lim Gavin W Lambert Karin A M Jandeleit-Dahm Mark E Cooper Merlin C Thomas Geoffrey A Head

Diabetologia 2020 07 5;63(7):1424-1434. Epub 2020 May 5.

Neuropharmacology Laboratory, Baker Heart and Diabetes Institute, P.O. Box 6492, Melbourne, VIC, 3004, Australia.

View Article and Find Full Text PDF

July 2020

Glucose and Blood Pressure-Dependent Pathways-The Progression of Diabetic Kidney Disease.

Authors:

Devang M Patel Madhura Bose Mark E Cooper

Int J Mol Sci 2020 Mar 23;21(6). Epub 2020 Mar 23.

Department of Diabetes, Monash University Central, Clinical School, Melbourne, VIC 3004, Australia.

View Article and Find Full Text PDF

March 2020

Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA trial.

Authors:

Nobuya Inagaki Wenying Yang Hirotaka Watada Linong Ji Sven Schnaidt Egon Pfarr Tomoo Okamura Odd Erik Johansen Jyothis T George Maximilian von Eynatten Julio Rosenstock Vlado Perkovic Christoph Wanner Mark E Cooper John H Alexander Issei Komuro Masaomi Nangaku

Diabetol Int 2020 Apr 22;11(2):129-141. Epub 2019 Oct 22.

16Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.

View Article and Find Full Text PDF

April 2020

Nox (NADPH Oxidase) 1, Nox4, and Nox5 Promote Vascular Permeability and Neovascularization in Retinopathy.

Authors:

Devy Deliyanti Saeed F Alrashdi Rhian M Touyz Christopher R Kennedy Jay C Jha Mark E Cooper Karin A Jandeleit-Dahm Jennifer L Wilkinson-Berka

Hypertension 2020 Apr 2;75(4):1091-1101. Epub 2020 Mar 2.

From the Department of Anatomy and Neuroscience, University of Melbourne, Victoria, Australia (D.D., J.L.W.-B.).

View Article and Find Full Text PDF

April 2020

Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo-controlled CARMELINA® trial.

Authors:

Mark E Cooper Julio Rosenstock Takashi Kadowaki Yutaka Seino Christoph Wanner Sven Schnaidt Douglas Clark Odd Erik Johansen

Diabetes Obes Metab 2020 07 27;22(7):1062-1073. Epub 2020 Feb 27.

Boehringer Ingelheim Norway KS, Asker, Norway.

View Article and Find Full Text PDF

July 2020

DIABETIC RETINOPATHY, CLASSIFIED USING THE LESION-AWARE DEEP LEARNING SYSTEM, PREDICTS DIABETIC END-STAGE RENAL DISEASE IN CHINESE PATIENTS.

Authors:

Lijun Zhao Honghong Ren Junlin Zhang Yana Cao Yiting Wang Dan Meng Yucheng Wu Rui Zhang Yutong Zou Huan Xu Lin Li Jie Zhang Mark E Cooper Nanwei Tong Fang Liu

Endocr Pract 2020 Apr 22;26(4):429-443. Epub 2020 Jan 22.

View Article and Find Full Text PDF

April 2020

Delineating a role for the mitochondrial permeability transition pore in diabetic kidney disease by targeting cyclophilin D.

Authors:

Runa S J Lindblom Gavin C Higgins Tuong-Vi Nguyen Maryann Arnstein Darren C Henstridge Cesare Granata Matthew Snelson Vicki Thallas-Bonke Mark E Cooper Josephine M Forbes Melinda T Coughlan

Clin Sci (Lond) 2020 Jan;134(2):239-259

Department of Diabetes, Central Clinical School, Alfred Medical Research and Education Precinct, Monash University, Melbourne, Victoria, Australia.

View Article and Find Full Text PDF

January 2020

A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerations.

Contemp Clin Trials 2020 03 16;90:105892. Epub 2019 Nov 16.

Baker Heart and Diabetes Institute, Level 4, Alfred Centre, 99 Commercial Road, Melbourne, VIC 3004, Australia. Electronic address:

View Article and Find Full Text PDF

March 2020

Renal protection: What have we learnt from ADVANCE about kidney disease in type 2 diabetes?

Authors:

Søren T Knudsen Mark E Cooper

Diabetes Obes Metab 2020 04;22 Suppl 2:12-18

Department of Diabetes, Monash University Central Clinical School, Melbourne, VIC, Australia.

View Article and Find Full Text PDF

April 2020

Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility.

Diabetes 2020 01 17;69(1):83-98. Epub 2019 Oct 17.

Department of Diabetes, Central Clinical School, Alfred Medical Research and Education Precinct, Monash University, Melbourne, Victoria, Australia

View Article and Find Full Text PDF

January 2020

Choice of endpoint in kidney outcome trials: considerations from the EMPA-REG OUTCOME® trial.

Authors:

Vlado Perkovic Audrey Koitka-Weber Mark E Cooper Guntram Schernthaner Egon Pfarr Hans J Woerle Maximilian von Eynatten Christoph Wanner

Nephrol Dial Transplant 2020 12;35(12):2103-2111

Department of Medicine, Würzburg University Clinic, Würzburg, Germany.

View Article and Find Full Text PDF

December 2020

The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study.

Authors:

Megumi Oshima Min Jun Toshiaki Ohkuma Tadashi Toyama Takashi Wada Mark E Cooper Samy Hadjadj Pavel Hamet Stephen Harrap Giuseppe Mancia Michel Marre Bryan Williams John Chalmers Mark Woodward Vlado Perkovic

Diabetologia 2019 11 13;62(11):1988-1997. Epub 2019 Jul 13.

The George Institute for Global Health, University of New South Wales, Sydney, Level 5, 1 King St, Newtown, NSW, 2042, Australia.

View Article and Find Full Text PDF

November 2019

Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial.

Authors:

Mark E Cooper Silvio E Inzucchi Bernard Zinman Stefan Hantel Maximilian von Eynatten Christoph Wanner Audrey Koitka-Weber

Am J Kidney Dis 2019 11 27;74(5):713-715. Epub 2019 Jun 27.

Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia; Boehringer Ingelheim International GmbH, Ingelheim; Department of Medicine, Würzburg University Clinic, Würzburg, Germany.

View Article and Find Full Text PDF

November 2019